Skip to main content
Top
Published in: BMC Nephrology 1/2016

Open Access 01-12-2016 | Research article

Comparison of vascular access outcomes in patients with end-stage renal disease attributed to systemic lupus erythematosus vs. other causes: a retrospective cohort study

Authors: Laura C. Plantinga, S. Sam Lim, Rachel E. Patzer, Stephen O. Pastan, Cristina Drenkard

Published in: BMC Nephrology | Issue 1/2016

Login to get access

Abstract

Background

U.S. hemodialysis patients with systemic lupus erythematosus (SLE) and end-stage renal disease (ESRD) are less likely than other ESRD patients to have a permanent vascular access (fistula or graft) in place at the dialysis start. We examined whether vascular access outcomes after dialysis start differed for SLE vs. other ESRD patients.

Methods

Among U.S. patients initiating hemodialysis in 2010 with only a catheter (n = 40,911; 384 with SLE) and using a permanent access on first dialysis (n = 13,073; 48 with SLE), we examined the association of SLE status with time to first placement of a permanent access (among catheter-only patients) and to loss of access patency (among patients using a permanent access on first dialysis), both censored 1 year after dialysis start, using multivariable Cox proportional hazards models.

Results

Among catheter-only patients, 46.1 % vs. 54.5 % of those with SLE-ESRD vs. other ESRD had a permanent access placed within 1 year after dialysis start. However, with adjustment, there was no association of 1-year placement with SLE status [HR = 1.00 (95 % CI, 0.86-1.17)]. SLE-ESRD vs. other ESRD patients starting dialysis with a permanent access were less likely to experience a 1-year loss of patency (43.8 % vs. 55.0 %), but this association was not statistically significant after adjustment [HR = 0.88 (0.57-1.37)].

Conclusion

These results suggest that SLE-ESRD patients starting dialysis with a catheter are not more likely to have a permanent access placed in the first year of dialysis, despite an observed lack of association of SLE status with subsequent loss of vascular access patency among those starting dialysis with a permanent access.
Appendix
Available only for authorised users
Literature
1.
go back to reference Pisoni RL, Young EW, Dykstra DM, Greenwood RN, Hecking E, Gillespie B, Wolfe RA, Goodkin DA, Held PJ. Vascular access use in Europe and the United States: results from the DOPPS. Kidney Int. 2002;61(1):305–16.CrossRefPubMed Pisoni RL, Young EW, Dykstra DM, Greenwood RN, Hecking E, Gillespie B, Wolfe RA, Goodkin DA, Held PJ. Vascular access use in Europe and the United States: results from the DOPPS. Kidney Int. 2002;61(1):305–16.CrossRefPubMed
2.
go back to reference Feldman HI, Kobrin S, Wasserstein A. Hemodialysis vascular access morbidity. J Am Soc Nephrol. 1996;7(4):523–35.PubMed Feldman HI, Kobrin S, Wasserstein A. Hemodialysis vascular access morbidity. J Am Soc Nephrol. 1996;7(4):523–35.PubMed
3.
go back to reference Dhingra RK, Young EW, Hulbert-Shearon TE, Leavey SF, Port FK. Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int. 2001;60(4):1443–51.CrossRefPubMed Dhingra RK, Young EW, Hulbert-Shearon TE, Leavey SF, Port FK. Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int. 2001;60(4):1443–51.CrossRefPubMed
4.
go back to reference Woods JD, Port FK. The impact of vascular access for haemodialysis on patient morbidity and mortality. Nephrol Dial Transplant. 1997;12(4):657–9.CrossRefPubMed Woods JD, Port FK. The impact of vascular access for haemodialysis on patient morbidity and mortality. Nephrol Dial Transplant. 1997;12(4):657–9.CrossRefPubMed
5.
go back to reference Xue JL, Dahl D, Ebben JP, Collins AJ. The association of initial hemodialysis access type with mortality outcomes in elderly Medicare ESRD patients. Am J Kidney Dis. 2003;42(5):1013–9.CrossRefPubMed Xue JL, Dahl D, Ebben JP, Collins AJ. The association of initial hemodialysis access type with mortality outcomes in elderly Medicare ESRD patients. Am J Kidney Dis. 2003;42(5):1013–9.CrossRefPubMed
6.
go back to reference Polkinghorne KR, McDonald SP, Atkins RC, Kerr PG. Vascular access and all-cause mortality: a propensity score analysis. J Am Soc Nephrol. 2004;15(2):477–86.CrossRefPubMed Polkinghorne KR, McDonald SP, Atkins RC, Kerr PG. Vascular access and all-cause mortality: a propensity score analysis. J Am Soc Nephrol. 2004;15(2):477–86.CrossRefPubMed
7.
go back to reference Pastan S, Soucie JM, McClellan WM. Vascular access and increased risk of death among hemodialysis patients. Kidney Int. 2002;62(2):620–6.CrossRefPubMed Pastan S, Soucie JM, McClellan WM. Vascular access and increased risk of death among hemodialysis patients. Kidney Int. 2002;62(2):620–6.CrossRefPubMed
8.
go back to reference Lee H, Manns B, Taub K, Ghali WA, Dean S, Johnson D, Donaldson C. Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. Am J Kidney Dis. 2002;40(3):611–22.CrossRefPubMed Lee H, Manns B, Taub K, Ghali WA, Dean S, Johnson D, Donaldson C. Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. Am J Kidney Dis. 2002;40(3):611–22.CrossRefPubMed
9.
go back to reference Vascular Access 2006 Work Group. Clinical practice guidelines for vascular access. Am J Kidney Dis. 2006;48(Suppl 1):S176–247. Vascular Access 2006 Work Group. Clinical practice guidelines for vascular access. Am J Kidney Dis. 2006;48(Suppl 1):S176–247.
11.
go back to reference Plantinga LC, Drenkard C, Patzer RE, Klein M, Kramer MR, Pastan S, Lim SS, McClellan WM. Sociodemographic and geographic predictors of quality of care in United States patients with end-stage renal disease due to lupus nephritis. Arthritis Rheumatol. 2015;67(3):761–72.CrossRefPubMed Plantinga LC, Drenkard C, Patzer RE, Klein M, Kramer MR, Pastan S, Lim SS, McClellan WM. Sociodemographic and geographic predictors of quality of care in United States patients with end-stage renal disease due to lupus nephritis. Arthritis Rheumatol. 2015;67(3):761–72.CrossRefPubMed
12.
go back to reference Plantinga LC, Patzer RE, Drenkard C, Pastan SO, Cobb J, McClellan W, Lim SS. Comparison of quality-of-care measures in U.S. patients with end-stage renal disease secondary to lupus nephritis vs. other causes. BMC Nephrol. 2015;16:39.CrossRefPubMedPubMedCentral Plantinga LC, Patzer RE, Drenkard C, Pastan SO, Cobb J, McClellan W, Lim SS. Comparison of quality-of-care measures in U.S. patients with end-stage renal disease secondary to lupus nephritis vs. other causes. BMC Nephrol. 2015;16:39.CrossRefPubMedPubMedCentral
13.
go back to reference O'Shaughnessy MM, Montez-Rath ME, Zheng Y, Lafayette RA, Winkelmayer WC. Differences in initial hemodialysis vascular access use among glomerulonephritis subtypes in the United States. Am J Kidney Dis. 2016;67(4):638–47.CrossRefPubMed O'Shaughnessy MM, Montez-Rath ME, Zheng Y, Lafayette RA, Winkelmayer WC. Differences in initial hemodialysis vascular access use among glomerulonephritis subtypes in the United States. Am J Kidney Dis. 2016;67(4):638–47.CrossRefPubMed
14.
go back to reference United States Renal Data System. 2015 USRDS annual data report: Epidemiology of kidney disease in the United States. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2015. United States Renal Data System. 2015 USRDS annual data report: Epidemiology of kidney disease in the United States. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2015.
15.
go back to reference Sule SD, Fadrowski JJ, Fivush BA, Gorman G, Furth SL. Reduced albumin levels and utilization of arteriovenous access in pediatric patients with systemic lupus erythematosus (SLE). Pediatr Nephrol. 2007;22(12):2041–6.CrossRefPubMed Sule SD, Fadrowski JJ, Fivush BA, Gorman G, Furth SL. Reduced albumin levels and utilization of arteriovenous access in pediatric patients with systemic lupus erythematosus (SLE). Pediatr Nephrol. 2007;22(12):2041–6.CrossRefPubMed
16.
go back to reference Sule SD, Fadrowski JJ, Fivush BA, Neu AM, Furth SL. Persistent low albumin and temporary vascular access in pediatric patients with SLE on hemodialysis. Pediatr Nephrol. 2009;24(10):1981–7.CrossRefPubMedPubMedCentral Sule SD, Fadrowski JJ, Fivush BA, Neu AM, Furth SL. Persistent low albumin and temporary vascular access in pediatric patients with SLE on hemodialysis. Pediatr Nephrol. 2009;24(10):1981–7.CrossRefPubMedPubMedCentral
17.
go back to reference Plantinga LC, Patzer RE, Drenkard C, Kramer MR, Klein M, Lim SS, McClellan WM, Pastan SO. Association of time to kidney transplantation with graft failure among US patients with end-stage renal disease due to lupus nephritis. Arthritis Care Res. 2015;67(4):571–81.CrossRef Plantinga LC, Patzer RE, Drenkard C, Kramer MR, Klein M, Lim SS, McClellan WM, Pastan SO. Association of time to kidney transplantation with graft failure among US patients with end-stage renal disease due to lupus nephritis. Arthritis Care Res. 2015;67(4):571–81.CrossRef
18.
go back to reference Mohan S, Huff E, Wish J, Lilly M, Chen SC, McClellan WM. Recovery of renal function among ESRD patients in the US Medicare program. PLoS One. 2013;8(12):e83447.CrossRefPubMedPubMedCentral Mohan S, Huff E, Wish J, Lilly M, Chen SC, McClellan WM. Recovery of renal function among ESRD patients in the US Medicare program. PLoS One. 2013;8(12):e83447.CrossRefPubMedPubMedCentral
19.
go back to reference Sato Y, Miyamoto M, Sueki S, Sakurada T, Kimura K, Nakazawa R, Yoshioka M, Sasaki H, Miyano S, Chikaraishi T. Risk factors associated with inadequate veins for placement of arteriovenous fistulas for hemodialysis. J Artif Organs. 2013;16(4):469–74.CrossRefPubMed Sato Y, Miyamoto M, Sueki S, Sakurada T, Kimura K, Nakazawa R, Yoshioka M, Sasaki H, Miyano S, Chikaraishi T. Risk factors associated with inadequate veins for placement of arteriovenous fistulas for hemodialysis. J Artif Organs. 2013;16(4):469–74.CrossRefPubMed
20.
go back to reference Muringai T, Noble H, McGowan A, Channey M. Dialysis access and the impact on body image: role of the nephrology nurse. Br J Nursing. 2008;17(6):362–6.CrossRef Muringai T, Noble H, McGowan A, Channey M. Dialysis access and the impact on body image: role of the nephrology nurse. Br J Nursing. 2008;17(6):362–6.CrossRef
21.
go back to reference Moroni G, Tantardini F, Ponticelli C. Renal replacement therapy in lupus nephritis. J Nephrol. 2003;16(6):787–91.PubMed Moroni G, Tantardini F, Ponticelli C. Renal replacement therapy in lupus nephritis. J Nephrol. 2003;16(6):787–91.PubMed
22.
go back to reference Perera GB, Mueller MP, Kubaska SM, Wilson SE, Lawrence PF, Fujitani RM. Superiority of autogenous arteriovenous hemodialysis access: maintenance of function with fewer secondary interventions. Ann Vasc Surg. 2004;18(1):66–73.CrossRefPubMed Perera GB, Mueller MP, Kubaska SM, Wilson SE, Lawrence PF, Fujitani RM. Superiority of autogenous arteriovenous hemodialysis access: maintenance of function with fewer secondary interventions. Ann Vasc Surg. 2004;18(1):66–73.CrossRefPubMed
23.
go back to reference Huber TS, Carter JW, Carter RL, Seeger JM. Patency of autogenous and polytetrafluoroethylene upper extremity arteriovenous hemodialysis accesses: a systematic review. J Vasc Surg. 2003;38(5):1005–11.CrossRefPubMed Huber TS, Carter JW, Carter RL, Seeger JM. Patency of autogenous and polytetrafluoroethylene upper extremity arteriovenous hemodialysis accesses: a systematic review. J Vasc Surg. 2003;38(5):1005–11.CrossRefPubMed
24.
go back to reference Saran R, Elder SJ, Goodkin DA, Akiba T, Ethier J, Rayner HC, Saito A, Young EW, Gillespie BW, Merion RM et al. Enhanced training in vascular access creation predicts arteriovenous fistula placement and patency in hemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study. Ann Surg. 2008;247(5):885–91.CrossRefPubMed Saran R, Elder SJ, Goodkin DA, Akiba T, Ethier J, Rayner HC, Saito A, Young EW, Gillespie BW, Merion RM et al. Enhanced training in vascular access creation predicts arteriovenous fistula placement and patency in hemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study. Ann Surg. 2008;247(5):885–91.CrossRefPubMed
25.
go back to reference Layton JB, Hogan SL, Jennette CE, Kenderes B, Krisher J, Jennette JC, McClellan WM. Discrepancy between Medical Evidence Form 2728 and renal biopsy for glomerular diseases. Clin J Am Soc Nephrol. 2010;5(11):2046–52.CrossRefPubMedPubMedCentral Layton JB, Hogan SL, Jennette CE, Kenderes B, Krisher J, Jennette JC, McClellan WM. Discrepancy between Medical Evidence Form 2728 and renal biopsy for glomerular diseases. Clin J Am Soc Nephrol. 2010;5(11):2046–52.CrossRefPubMedPubMedCentral
26.
go back to reference Plantinga LC, Drenkard C, Pastan SO, Lim SS. Attribution of cause of end-stage renal disease among systemic lupus erythematosus patients: the Georgia Lupus Registry. Lupus Sci Med. 2016;3(1):e000132.CrossRefPubMedPubMedCentral Plantinga LC, Drenkard C, Pastan SO, Lim SS. Attribution of cause of end-stage renal disease among systemic lupus erythematosus patients: the Georgia Lupus Registry. Lupus Sci Med. 2016;3(1):e000132.CrossRefPubMedPubMedCentral
Metadata
Title
Comparison of vascular access outcomes in patients with end-stage renal disease attributed to systemic lupus erythematosus vs. other causes: a retrospective cohort study
Authors
Laura C. Plantinga
S. Sam Lim
Rachel E. Patzer
Stephen O. Pastan
Cristina Drenkard
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2016
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-016-0274-y

Other articles of this Issue 1/2016

BMC Nephrology 1/2016 Go to the issue